Merck & Co. Inc. [NYSE: MRK] traded at a low on 07/19/21, posting a -1.24 loss after which it closed the day’ session at $77.05. The company report on July 17, 2021 that Merck Announces U.S. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Caused by 15 Serotypes.
Clinical Data Supporting Approval Demonstrated Non-Inferior Immune Responses for the Serotypes Shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F).
VAXNEUVANCE Elicited Superior Immune Responses for Serotypes 3, 22F and 33F Compared to PCV13, Which Are Major Causes of Disease.
The results of the trading session contributed to over 9717491 shares changing hands. Over the past one week, the price volatility of Merck & Co. Inc. stands at 1.34% while the volatility over the past one month is 1.19%.
The market cap for MRK stock reached $194.79 billion, with 2.53 billion shares outstanding and 2.53 billion shares in the current float. Compared to the average trading volume of 12.27M shares, MRK reached a trading volume of 9717491 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Merck & Co. Inc. [MRK]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRK shares is $93.02 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRK stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Argus have made an estimate for Merck & Co. Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on May 20, 2021. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Sector Perform. The new note on the price target was released on April 07, 2021, representing the official price target for Merck & Co. Inc. stock. Previously, the target price had yet another raise to $95, while Bernstein analysts kept a Outperform rating on MRK stock.
The Average True Range (ATR) for Merck & Co. Inc. is set at 1.08, with the Price to Sales ratio for MRK stock in the period of the last 12 months amounting to 4.06. The Price to Book ratio for the last quarter was 7.23. Price to Free Cash Flow for MRK in the course of the last twelve months was 993.85 with Quick ratio for the last quarter at 0.80.
How has MRK stock performed recently?
Merck & Co. Inc. [MRK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.64. With this latest performance, MRK shares dropped by -0.23% in over the last four-week period, additionally sinking by -3.09% over the last 6 months – not to mention a rise of 1.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MRK stock in for the last two-week period is set at 50.76, with the RSI for the last a single of trading hit 43.33, and the three-weeks RSI is set at 49.51 for Merck & Co. Inc. [MRK]. The present Moving Average for the last 50 days of trading for this stock 77.07, while it was recorded at 77.64 for the last single week of trading, and 78.09 for the last 200 days.
Merck & Co. Inc. [MRK]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Merck & Co. Inc. [MRK] shares currently have an operating margin of +26.16 and a Gross Margin at +73.77. Merck & Co. Inc.’s Net Margin is presently recorded at +14.72.
Return on Total Capital for MRK is now 22.39, given the latest momentum, and Return on Invested Capital for the company is 13.93. Return on Equity for this stock inclined to 27.59, with Return on Assets sitting at 8.03. When it comes to the capital structure of this company, Merck & Co. Inc. [MRK] has a Total Debt to Total Equity ratio set at 132.14. Additionally, MRK Total Debt to Total Capital is recorded at 56.92, with Total Debt to Total Assets ending up at 36.53. Long-Term Debt to Equity for the company is recorded at 105.55, with the Long-Term Debt to Total Capital now at 45.47.
Reflecting on the efficiency of the workforce at the company, Merck & Co. Inc. [MRK] managed to generate an average of $95,500 per employee. Receivables Turnover for the company is 6.56 with a Total Asset Turnover recorded at a value of 0.55.Merck & Co. Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 1.00.
Earnings analysis for Merck & Co. Inc. [MRK]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MRK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Merck & Co. Inc. go to 10.82%.
Insider trade positions for Merck & Co. Inc. [MRK]
There are presently around $143,368 million, or 75.10% of MRK stock, in the hands of institutional investors. The top three institutional holders of MRK stocks are: VANGUARD GROUP INC with ownership of 225,205,929, which is approximately 8.059% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 193,928,410 shares of the stock with an approximate value of $14.94 billion in MRK stocks shares; and STATE STREET CORP, currently with $8.68 billion in MRK stock with ownership of nearly -1.282% of the company’s market capitalization.
Positions in Merck & Co. Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 1,414 institutional holders increased their position in Merck & Co. Inc. [NYSE:MRK] by around 93,452,817 shares. Additionally, 1,131 investors decreased positions by around 105,055,153 shares, while 277 investors held positions by with 1,662,202,693 shares. The mentioned changes placed institutional holdings at 1,860,710,663 shares, according to the latest SEC report filing. MRK stock had 139 new institutional investments in for a total of 6,589,442 shares, while 135 institutional investors sold positions of 6,752,908 shares during the same period.